C 反应蛋白和降钙素原在新生儿ABO溶血病中的临床意义

孙海潮1，苗伶俐1，2 ，屈伟3 *

（榆林市星元医院：1. 检验科；2. 输血科，陕西 榆林，791000；3.陕西省靖边县中医院检验科，陕西 榆林，718500）

浏览次数：138次 下载次数：358次

摘要：

目的 探讨新生儿ABO 溶血病合并感染患儿的C 反应蛋白（CRP）、降钙素原（PCT）变化特点。方法 择取我院收治的 ABO 溶血患儿100 例，按照患儿是否存在感染情况，划分为感染组（n=53）和非感染组（n=47）。回顾分析两组患儿的临床资 料，分析比较两组的诊断结果。结果 非感染组患儿入院第1、3 天的PCT、CRP 水平均明显低于感染组患儿（P<0.05）。非感染组患儿PCT、CRP 异常值检出率均明显低于感染组患儿（P<0.05）。感染诊断过程中，PCT 准确度、特异度以及灵敏度均明显 优于CRP（P<0.05）。结论 ABO 溶血病合并感染患儿的CRP、PCT 水平相对较高，PCT 诊断相对于CRP 具有更高的准确性、特异度、灵敏度。

关键词：C 反应蛋白；降钙素原；新生儿ABO 溶血病

中图分类号：R722.1文献标志码：A文章编号：2096-1413(2018)03-0107-02

Clinical significance of C-reactive protein and procalcitonin in ABO hemolytic disease of newborns
SUN Hai-chao 1, MIAO Ling-li 1, 2, QU Wei 3 *
( 1. Laboratory Department; 2. Blood Transfusion Department, Xingyuan Hospital of Yulin, Yulin 791000; 3. Laboratory Department, Traditional Chinese Medicine Hospital of Jingbian County, Yulin 718500, China)

ABSTRACT: Objective To investigate the changes of C-reactive protein (CRP) and procalcitonin (PCT) in newborns with ABO hemolytic disease complicated infection. Methods A total of 100 children with ABO hemolysis admitted in our hospital were divided into infection group (n=53) and non-infection group (n=47) according to the presence or absence of infection. The clinical data of the two groups were retrospectively analyzed, and the diagnostic results of the two groups were analyzed and compared. Results The levels of PCT and CRP on the first day and the third day after admission in the non-infected group were significantly lower than those in the infection group (P<0.05). The detection rates of abnormal values of PCT and CRP in the non-infected group were significantly lower than those in the infection group (P<0.05). During the diagnosis of infection, the accuracy, specificity and sensitivity of PCT were significantly better than those of CRP (P<0.05). Conclusion The levels of CRP, PCT in children with ABO hemolytic disease associated with infection are relatively high. Compared with CRP, the diagnostic performance of PCT has high accuracy, specificity and sensitivity.
KEYWORDS: C-reactive protein; procalcitonin; ABO hemolytic disease of newborns

参考文献：
[1] BEKEN S,HIRFANOGLU I,TURKYILMAZ C,et al.Intravenous immunoglobulin G treatment in ABO hemolytic disease of the newborn, is it myth or real? [J].Indian J Hematol Blood Transfus,2014,30 (1): 12-15.
[2] 周益强,肖倩,冯尚克,等.IgG 亚型与新生儿ABO 溶血病的相关性 [J].广东医学,2011,32(2):182-184.
[3] 李伟生,杨辅直,陈晓玲,等.新生儿ABO 溶血病早期诊治及转归分 析[J].广东医学,2012,33(10):1429-1430.
[4] 卜祥茂,梁弘刚,宋金莲,等.新生儿ABO 溶血病实验诊断的方法学 探讨[J].中国实验诊断学,2013,17(12):2205-2207.
[5] 古丽,黄薇,董文斌,等.血型及首次出现黄疸时间与新生儿ABO 溶 血病的相关性[J].西部医学,2016,28(3):385-388,392.
[6] 孙海芳,喻芳明,方巧兰.新生儿ABO 溶血病患儿母亲孕期IgG 抗 A/B 效价的动态监测[J].检验医学,2011,26(12):850-853.
[7] 贾金平,黄小霞.脐带血血清学检测在新生儿ABO 溶血病早期诊 断中的应用[J].现代中西医结合杂志,2015,24(2):161-163.
[8] 郑润桃,闫晓芳.血清酌-痕迹蛋白及总胆汁酸在判断ABO 溶血病 新生儿肝肾功能损害中的价值[J].中国医学前沿杂志:电子版,2016,8(5):119-122.
[9] 裴夏南,钱新华,丁静.C 反应蛋白和降钙素原在新生儿ABO 溶血病中的临床意义[J].山西医科大学学报,2014,45(5):391-395.